STAT3 and B-cell non-Hodgkin lymphoma: This extends to a susceptibility to immune cell cancers, with SNPs in STAT3 and STAT5A being implicated in B cell lymphoma risk and SNPs in STAT3 and STAT6 in Hodgkin lymphoma risk [88].